Immunotherapy of melanoma.

Immunotherapy of melanoma.

Detalles Bibliográficos
Main Authors:	Smith, C, Cerundolo, V
Formato:	Journal article
Idioma:	English
Publicado:	2001

Títulos similares

IMMUNOTHERAPY FOR MELANOMA
por: E. A. Borobova, et al.
Publicado: (2017-09-01)

Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.
por: Hermans, I, et al.
Publicado: (2003)

Immunotherapy of colorectal cancer.
por: Smith, C, et al.
Publicado: (2002)

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.
por: Dunbar, P, et al.
Publicado: (1999)

Immunotherapy and delivery systems for melanoma
por: Hui Liu, et al.
Publicado: (2024-12-01)

Editorial: The role of immunotherapy in melanomas
por: Anna Fateeva, et al.
Publicado: (2023-09-01)

Current application of immunotherapy in melanoma
por: Ruxin Xie, et al.
Publicado: (2023-05-01)

The use of immunotherapy in the treatment of melanoma
por: Tala Achkar, et al.
Publicado: (2017-04-01)

Cancer immunology and melanoma immunotherapy
por: Rudinei Diogo Marques Linck, et al.
Publicado: (2017-12-01)

The age of enlightenment in melanoma immunotherapy
por: Mark R. Albertini
Publicado: (2018-08-01)

Progress in immunotherapy for brain metastatic melanoma
por: Shicheng Zheng, et al.
Publicado: (2025-01-01)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Oliver Kepp, et al.
Publicado: (2023-12-01)

Advances in predictive biomarkers for melanoma immunotherapy
por: Wenjie Ma, et al.
Publicado: (2024-10-01)

Editorial of special focus on melanoma immunotherapy
por: Ernesto Rossi
Publicado: (2022-05-01)

Immunotherapy in the management of melanoma: current status
por: Alston D, et al.
Publicado: (2013-02-01)

Melanoma Immunotherapy: Next-Generation Biomarkers
por: Sabrina A. Hogan, et al.
Publicado: (2018-05-01)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Diogo Garcia, et al.
Publicado: (2021-06-01)

Targeting regulatory T cells for immunotherapy in melanoma
por: Lili Huang, et al.
Publicado: (2021-04-01)

Melanoma immunotherapy: dendritic cell vaccines
por: Ivan Lozada-Requena, et al.
Publicado: (2015-09-01)

Unraveling the Impact of Microbiome on Immunotherapy Efficacy in Melanoma
por: J. Bagué Companys, et al.
Publicado: (2024-01-01)

Peripheral T cell responses to immunotherapy treatment in metastatic melanoma
por: Woodcock, V
Publicado: (2019)

Efficiency of ADOPTIVE immunotherapy for melanoma: a case REPORT
por: E. V. Abakushina, et al.
Publicado: (2016-11-01)

Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
por: Shravan Leonard-Murali, et al.
Publicado: (2024-04-01)

Advances in Immunotherapy and Targeted Therapy of Malignant Melanoma
por: Xue Wang, et al.
Publicado: (2025-01-01)

Adjuvant and neoadjuvant immunotherapy for acral and mucosal melanoma
por: Takaya Komori, et al.
Publicado: (2025-01-01)

Advances in Immunotherapy for Melanoma: A Comprehensive Review
por: Carmen Rodríguez-Cerdeira, et al.
Publicado: (2017-01-01)

Immunotherapy for anorectal melanoma: A case report
por: Nicholas L. Vitagliano, et al.
Publicado: (2024-09-01)

Immunotherapy in melanoma: advances, pitfalls, and future perspectives
por: Cristina Sorino, et al.
Publicado: (2024-06-01)

Role of gut microbiome on immunotherapy efficacy in melanoma
por: Stefano Bibbò, et al.
Publicado: (2022-05-01)

Glycan targeting nanoparticle for photodynamic immunotherapy of melanoma
por: Yonghyun Choi, et al.
Publicado: (2023-05-01)

Beyond PD-1 Immunotherapy in Malignant Melanoma
por: Dominika Kwiatkowska, et al.
Publicado: (2019-03-01)

Immunotherapy in the Precision Medicine Era: Melanoma and Beyond.
por: Mack Y Su, et al.
Publicado: (2016-12-01)

Machine learning-based identification of an immunotherapy-related signature to enhance outcomes and immunotherapy responses in melanoma
por: Zaidong Deng, et al.
Publicado: (2024-09-01)

Modern combined targeted and immunotherapy of metastatic skin melanoma
por: S. A. Protsenko, et al.
Publicado: (2020-12-01)

Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients.
por: Cerundolo, V
Publicado: (2000)

New combinations and immunotherapies for melanoma: latest evidence and clinical utility
por: Alexander M. Menzies, et al.
Publicado: (2013-09-01)

Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers
por: Taku Fujimura, et al.
Publicado: (2020-07-01)

Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma
por: Joel Ho, et al.
Publicado: (2022-10-01)

Use of Immunotherapy and Radiation Treatment in the Management of Metastatic Melanoma With Rhabdomyosarcomatous Differentiation
por: Apar Gupta, MD, MBA, et al.
Publicado: (2020-01-01)

Adjuvant lymph node radiotherapy and immunotherapy in stage III melanoma
por: L. Marxgut, et al.
Publicado: (2024-01-01)